Pharmaceutical US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision on its claims in the dispute with its partner, Japan's biggest drugmaker Takeda Pharmaceutical (TYO: 4502), saying the International Court of Arbitration, International Chamber of Commerce (ICC) did not agree with Sucampo's claims and did not award any attorneys' fees or costs. Predictably, Sucampo expressed its disappointment with the ICC's decision. Shares in the US company slumped, closing trading on Friday down 25% at $5.23. 9 July 2012